Companies: 10,795·Total market cap: $144.5T
Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

DCHPFOTCHealthcare
$46.90
$-0.10(-0.21%)
Market Cap$5.3B
P/E Ratio
52W High$47.4
52W Low$30.0

Dechra Pharmaceuticals PLC (DCHPF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

DCHPF · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.
No earnings history available.
No analyst estimates available for DCHPF.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: DCHPF ends December

Dechra Pharmaceuticals PLC (DCHPF) reports earnings quarterly as a OTC-listed Medical - Pharmaceuticals company. The next DCHPF earnings date is expected around September 1, 2026.

Each quarter, investors track DCHPF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DCHPF revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DCHPF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

DCHPF earnings · 3 questions

Dechra Pharmaceuticals PLC's next earnings report is expected around September 1, 2026. DCHPF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DCHPF historically reports after market close (AMC).

DCHPF earnings datewhen is DCHPF earningsDCHPF next earnings datewhen does DCHPF report earningsDCHPF earnings calendar

Source: FMP · Dechra Pharmaceuticals PLC SEC filings · US GAAP · Dechra Pharmaceuticals PLC SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026